A wearable hemofilter for continuous ambulatory ultrafiltration

Area of Science:

• Nephrology
• Biomedical Engineering

Background:

• Fluid overload is a common complication in patients with heart failure, often requiring dialysis.
• Current ultrafiltration methods are not suitable for ambulatory treatment, limiting patient mobility and quality of life.

Purpose of the Study:

• To evaluate the safety and efficacy of a novel light-weight wearable continuous ambulatory ultrafiltration device for treating fluid overload.

Main Methods:

• The study involved six volume-overloaded patients who underwent a 6-hour ultrafiltration treatment using a wearable device.
• The device comprised a hollow fiber hemofilter, a battery-operated pulsatile pump, and micropumps for heparin and ultrafiltration control.
• Treatment involved an average blood flow of 116 ml/min and an ultrafiltration rate of 120-288 ml/h, with sodium removal of approximately 150 mmol.

Main Results:

• The wearable hemofilter was found to be safe and effective, with stable blood pressure, pulse, and biochemical parameters.
• No significant hemolysis or complications were observed in the majority of patients.
• One patient discontinued treatment due to a clotted catheter, highlighting a potential area for improvement.

Conclusions:

• The wearable continuous ambulatory ultrafiltration device is a practical and promising option for managing fluid overload in heart failure patients.
• This technology has the potential to significantly enhance the quality of life for individuals suffering from fluid overload.
• Further research is warranted to confirm these preliminary findings and explore wider applications.